Neuphoria Therapeutics Inc (NEUP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.80M
Last updated: Nov 17, 2026 at 11:04 AM ET
Neuphoria Therapeutics Inc (NEUP) Stock Forecast
Analysts expect Neuphoria Therapeutics (NEUP) to earn -$2.43 per share in the fiscal year ending Jun 30, 2027. Over the last 30 days, 0 estimates for the fiscal year ending Jun 30, 2027 were revised up and 1 down. For the fiscal year ending Jun 30, 2028, the EPS consensus is -$2.46.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Jun 30, 2027
- -$2.43
- EPS consensus
- Fiscal year ending Jun 30, 2028
- -$2.46
- EPS consensus
- Next report
- Nov 18, 2026
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Jun 30, 2027 | -$2.43 | -$2.43 to -$2.43 | 1 |
| Jun 30, 2028 | -$2.46 | -$2.46 to -$2.46 | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jun 30, 2027 | 0 | 1 |
| Fiscal year ending Jun 30, 2028 | 0 | 0 |
EPS Trend
The EPS consensus for the fiscal year ending Jun 30, 2027 has held over the last 90 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Jun 30, 2027 | -$2.43 | -$2.43 | -$2.43 | -$2.43 | -$2.43 | N/A |
| Fiscal year ending Jun 30, 2028 | -$2.46 | -$2.46 | -$2.46 | -$2.46 | -$2.46 | N/A |
Frequently Asked Questions About NEUP
What is the NEUP stock forecast?
Consensus analyst estimates put Neuphoria Therapeutics's EPS at -$2.43 for the fiscal year ending Jun 30, 2027.
What EPS do analysts expect from NEUP next year?
For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$2.43, with estimates from -$2.43 to -$2.43 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$2.46, with estimates from -$2.46 to -$2.46 from 1 analyst.
How many analysts cover NEUP?
1 analyst estimates EPS for Neuphoria Therapeutics for the fiscal year ending Jun 30, 2027.
NEUP pages: Overview, Earnings, Forecast, Financials, Competitors